Skip to content

New Feature: Text Message Treatment Updates

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated texts with the intention of collecting data on their medical cannabis treatment outcomes.

How It Works

When creating a new patient case, physicians input the patient’s phone number along with all other relevant information. Once a phone number is entered, a drop-down box will appear offering the physician to choose if the patient has opted in for text message updates. These text message updates will automatically be sent to the patient at a specific date and time with a request to rate their treatment efficacy on a scale of one (Adverse Reaction) to five (Total Resolution of Symptoms). All the patient will then have to do is respond with a number (1 through 5), and the data is collected in their case file.

The Benefit

“We want to ensure that physicians have real-time responses from their patients about their medical cannabis treatment plans,” said James West, founder and CEO of Arfinn Med. “Several states have long durations between required appointments, so physicians need to have tools to track their patients’ progress and create an open dialogue during a treatment period to increase the likelihood that the treatment plan will be further customized for the patient.”

Providing this type of feature will significantly save physicians time when collecting updates from patients. Instead of lengthy office visits or following up via phone call, one text can collect all the information needed. All data received through this text messaging feature is a real time update to help give a full picture of how that specific treatment is affecting each patient. Along with saving both the physician and patient time, this feature is also expected to increase patient retention. With such a hands-on approach, the text messaging feature will encourage patients to keep their physicians updated and refine the treatment plan, if/as needed, to obtain the results they desire.


At Arfinn Med, we are dedicated to helping medical professionals and their patients combat debilitating diseases and conditions with the use of medical marijuana. By relying on actual physician observations regarding patient outcomes, doctors can create reports based on the effectiveness, daily dosage and delivery mode of cannabis treatments specific to various patient demographics. Are you ready to join a nationwide network of medical professionals to learn more about medical marijuana and what it can do for your patients? Join Arfinn Med for FREE today!

Stories you may be interested in

World Cancer Day – Shine a Light on the World

In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More

Norfolk research company plans clinical trials using medical marijuana

Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More

Assessing Health-Related Outcomes of Medical Cannabis Use among Older Persons: Findings from Colorado and Illinois

ABSTRACT Objectives To assess health-related outcomes associated with medical cannabis use among older patients in Colorado and Illinois enrolled in their home state’s medical cannabis program. Methods Cross-sectional data from anonymous surveys were collected from 139 persons over the age of 60 using medical cannabis in the past year. We used structural equation modeling (SEM)…
Read More

Doctors and patients are flying blind as medical marijuana use rises, research lags

Marijuana’s role in the health care universe has grown exponentially over the past few years. Currently, 33 U.S. states have legalized the use of medical marijuana, and more and more states are considering making it legal for recreational purposes as well. As cannabis becomes more accessible, many people are turning to tetrahydrocannabinol (THC) and cannabidiol (CBD) products to…
Read More

Older adults and medical marijuana: Reduced stigma and increased use

As a primary care doctor who has incorporated medical cannabis into his practice, it is notable how many silver-haired patients are coming in to discuss the pros and cons of a trial of medical cannabis. These patients range from people in their 60s with kidney failure who can no longer take certain pain medications but…
Read More

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More